Wishing all a blessed happy chinese new year 2021

Wishing all a blessed happy chinese new year 2021

The Edge reported Supermax is the top gainer in 2020 - Koon Yew Yin
Author: Koon Yew Yin Publish date: Sat, 2 Jan 2021, 12:48 PM

KUALA LUMPUR (Dec 31): Although the battle with Covid-19 pandemic is still ongoing, Bursa Malaysia certainly has good reasons to celebrate the year 2020.

Firstly, the local market has outperformed its neighbouring bourses with its benchmark index ending the year in the positive zone, except for Vietnam. The FBM KLCI gained 3.5% year-to-date (YTD) to reach 1,644.41 points on Dec 30, while Vietnam's VNINDEX has climbed 14.2% YTD. It is worth noting that the FBM KLCI had declined for two consecutive years since 2017.

In contrast, Singapore's Straits Times Index dropped 11% YTD, followed by the Philippines' PSE Composite Index -8.6%, Thailand's SET Index -8.3%, and Indonesia's Jakarta Composite Index -5.1%.

Share prices went higher in the broader market, as reflected by the bigger gains on Bursa Malaysia Small Cap Index, which went up 10.09%, while FTSE Bursa Malaysia ACE Index, which exceeded the 10,000 mark, has soared 103.5% YTD.

The market capitalisation of all listed entities has ballooned as much as RM104.74 billion against end-2019's, according to Bloomberg data.

Secondly, the stock exchange should also cheer for the return of retail investors who have been absent for over a decade, if not longer. Given the surge in retail interest, the exchange's daily trading volume ballooned to an all-time high of 27.8 billion in August compared with last year's high of 2.51 billion shares.

Bursa's total trading volume swelled to 1.81 trillion as at Dec 30, nearly triple of 2019's annual volume of 613.59 billion. This speaks well for Bursa Malaysia Bhd's earnings.

Rubber glove makers, semiconductor-related counters and vaccine distributors — these are the main theme plays in 2020.

The Edge is taking a closer look at this year's top winners and top losers, which have been grouped according to market capitalisation.





Super big cap (market cap of more than RM10 billion)

There are 37 companies in this category. Supermax Corp Bhd and Kossan Rubber Industries Bhd were not in this category last year. Likewise, so was not the newly listed Mr DIY Group (M) Bhd.

The top four best performers are the big four rubber glove makers, namely Supermax (+802% YTD), Top Glove Corp Bhd (+291% YTD), Kossan (+130% YTD) and Hartalega Holdings Bhd (+120% YTD). They would have recorded higher gains this year if it were not for the news about the roll-out of Covid-19 vaccines most recently. They have collectively gained RM79.42 billion worth of market cap, which is equivalent to 76% of the total market cap increases from all the stocks listed on Bursa Malaysia.

My comment: Due to the Covid 19 pandemic, the demand for medical gloves far exceeds supply. As a result, all the glove maker can easily continue to increase their selling prices to make more and more profit. The number of Covid 19 cases are still increasing more and more every day as shown by the chart below.



Currently US has a total of 20.45 million cases and 354,215 deaths. These figures are still surging.

Supermax is the top performer in 2020

From this report, you can see that Supermax has gained 802% and Top Glove has gained 291% in 2020. Supermax is the top gainer among all the 1,100 listed companies because it has the best profit growth rate. Its EPS was 30.58 sen for its 1st quarter ending September. Its EPS was 15.29 sen for its previous quarter. It made 100% more profit than its previous quarter. It is most likely its 2nd quarter profit will be another new record high which will be announced in Mid-January.

Even if I assume that Supermax cannot increase its selling price for the 3 quarters, its annual EPS will be 30.58 sen X 4 = Rm 1.22. Based on PE 15 its share price should Rm 18.30.

These photos below are showing that all the medical staff are wearing glove to do the vaccination and testing for coronavirus. In fact, additional glove will be required. Unfortunate, many less informed investors are rushing to sell their holdings as if the vaccine will reduce the demand for gloves.







I am obliged to inform you that 90% of my investment is Supermax and 10% is Top Glove. I am not encouraging you to buy or sell because your trading volume will not affect the share price as the daily traded volume is tens of million shares.

https://www.klsescreener.com/v2/news/view/773059

https://klse.i3investor.com/m/blog/koonyewyinblog/2020-12-30-story-h1538456927-Supermax_price_drop_is_so_illogical_Koon_Yew_Yin.jsp

https://klse.i3investor.com/m/blog/koonyewyinblog/2020-12-30-story-h1538456927-Supermax_price_drop_is_so_illogical_Koon_Yew_Yin.jsp

https://www.klsescreener.com/v2/news/view/772121

Wishing you all the best for 2020 and 2021

Those glove co with good accomodation for their employees should not affected but accomodation like Brightways provided for their employees certainly will be affected.

Brightways holding sdn bhd belongs to which listed co?

https://www.klsescreener.com/v2/news/view/771091

Fundamental value will surface with projected EPS of RM1.48 for 2021. Not many listed co can have that EPS. At PE 8, price will be RM11. 8

KUALA LUMPUR: Copper products maker Ta Win Holdings Bhd’s healthcare subsidiary, Ta Win Copper Biohealth Sdn Bhd (TWCB), has completed the acquisition of a 32.5 per cent equity interest stake in Royce Pharma Manufacturing Sdn Bhd for RM20.85 million.

In a statement today, Ta Win group managing director Datuk Seri Ngu Tieng Ung said the acquisition would enable the group to capitalise on Royce Pharma’s robust pharmaceutical capabilities and experience.

"As our first foray into the pharmaceutical industry, which holds vast prospects, this positions us well to leverage on Royce Pharma’s expertise and strong track record in the sector.

"Building on this, we are confident that this will contribute to the group's performance moving forward," he said.

Ngu said following this acquisition, the group aimed to tap into viable opportunities, including the development of pharmaceutical products that meet evolving global healthcare needs, particularly during the COVID-19 pandemic.

"We will continue to look into downstream applications of the biochemistry and chemistry of copper and copper proteins to further strengthen our prospects over the long term,” he added.

The acquisition was concluded in accordance with the terms and conditions of the share sale agreement (SSA) and subscription agreement.

The profit guarantee agreement and shareholders agreement have also become unconditional effective today. - Bernama

TAGS: Ta Win Copper Biohealth Sdn Bhd, Ta Win, Ngu Tieng Ung, Acquisition, Royce Pharma

Can anyone who visited the production factory update the latest production status or has production trial run started?

Can anyone report when AT is producing the first medical glove?

Is AT medical glove plant a high tech with minium workers? When is the actual production date?

Mr Koon should not have written the 2 artiicles in the first place as directors and employees are buying at 26 cents.

5 years ago, the share price was RM14 plus. After 5 years of increasing profit and upon uplift of suspension, it is very odd and unusual for the share price to drop by more than 50% from RM14 plus to RM7.1 and US is on historical high of about 30,000 points. Could it be massive undervalued as Hong Leong group is a well managed group.

Will it become Pharma or Dpharma as the government is supporting Prlexus anti covid 19 face mask technology?

The most effective anti covid 19 with more than 99% face mask from Prlexus has its latest quarterly profit of RM23.9M, 181m shares compared SCGM of RM8.3M, 193m sjares, what is the target price for PRlexus currently at 1.76 compared to SCGM of 3.19?

Why prlexus is the most under valued face mask stock? Among all the face mask stocks, prlexus profit growth for the latest quarter ended 31.7.2020 was from the loss of 8m to 23.9m or more than 23.9m%. Share base only 181m, NTA 1.41 & PE 17.17 currently at price of 1.67. Let take a look at SCGM, another established face mask stock currently at price of 3.13 with latest profit of 8.3m, NTA 0.91, PE 25.96 and share base of 193m.

This is one of the best face mask against covid 19 prevention and has the best profit growth from RM8m loss to profit growth of Rm23.8m.

Big international investment bankers, Citigroup, UBS and China international Capital Corporation are promoting Top Glove to be listed in Hong Kong.

Consistent buy back by the company is the reflection of much undervalued shares and far sighted of the top management decision.

Profit of RM10b over 8,128k shares

Macquarie TP is RM5. 4 and EPS is RM1. 21 for 12 months which gives a PE of 4.46. Is it becoming the cheapest blue chip company in KLSE? Or currently trading at the PE of 5.44 based on his EPS of RM1. 21 which Is massively undervalued now?

When can we see the beauty of supernormal profit for glove companies? Just starting?

https://www.straitstimes.com/asia/se-asia/top-glove-boss-shuns-profligacy-even-as-firm-rises-to-the-top

即时国内/ 【独家】 顶级手套股价贵？林伟才：投资最重要看价值 https://www.sinchew.com.my/pad/con/content_2325395.html (Share from StockHunter)

MD one stop centre is best with prevention plus cure, that is glove, face mask, sanitizer, ventilator and vaccine.

A very good article written by Mr KYY and Affin Hwang Research analyst Mr Ngu on target price of Top Glove. If you read the articles written by Mr KYY on target price of Comfort and Supermax in the past few months, todate the target price has achieved almost 80% to 90%. God bless all to realise the dream of RM100.

Existing Top glove EPS is 24.23 and Supermax EPS is 10.37. TOP glove has the highest EPS among big 4 and among big 7. Why top glove is so laggard behind?

Supermax has 27b production capacity and Top Glove has 84b production capacity. Supermax has up 10 times from 2 to almost 20, will top glove up 6 to 60 as it has 3 times more production capacity than supermax?

Careplus is the only malaysian glove company having 50% joint venture with Ansell, an Australian listed healthcare company valued at AUD38. 80, will careplus follow the footsteps of Ansell?

Excellent performance and reward to shareholders with 2 bonus shares for one ordinary share.

Penny investment of 12.2m can make a guaranteed profit of 5.6m or 46% return or annual return of 23% is a good investment decision.

Another great written article on revision of target price of comfort by Mr Koon. You are the best leader in motivating the investors in investment. Comfort is the cheapest in terms of PE and the highest EPS growth in the last 3 quarters among all the glove companies.

The profit growth of comfort is impressive for the last 3 quarters from 7.4m as at 31.10.2019 to 10.2m as at 31.1.2020 and to 16.3m as at 30.4.2020 and will be more impressive for the next 4 quarters as sales are confirmed for the next 400 days. Where to find such a profitable company in klse during this crisis? Glove industry is the best sector for prevention of covid 19.

Excellent written article by Mr Koon who has hands on contact with Mr khoo, CEO of Ruberex about the super great demand for gloves. This is tbe best sector in the world market for prevention of covid 19.

You did a very good homework and a very good analysis and comparison among the big 2 and a younger and beautiful comfort which most iinvestment bankers have not done it but may be pushing down the share for the past 5 days so that they can buy cheaper shares. EPS growth and PE are the most crucial to value a company and definitely this young boy is undervalued compared to the big 2 men which all the investment bankers have made very good comments.

https://www.klsescreener.com/v2/news/view/687947

Super great demand for glove business for top glove as sales orders placed today will be delivered in 400 days and generated super profit for the next 400 days at least. This will apply to comfort as well for super profit for the next 400 days at least.

The top management have a duty to disclose to investors why your revenue drop from the last quarter of RM109m to RM105m despite increase in selling price, foreign exchange of USD, decrease in raw material costs compared to supermax which increase so much in their revenue.

Based on 2018 audited annual report, it has production capacity of 4.14 billion pieces of gloves per annum which is the big 6 of the 7 listed glove companies. If we base on the market capitalisation over 4.14b, the market value per piece is only RM0.233 compare to top glove of RM0. 483 based on 84b and Ruberex of RM0.42 based on 3b. They also mention to increase the production to 10b by 2020 which will be RM0. 0967 per piece. Due to recession in crude oil and rubber, they can buy cheap raw materials and super demand for glove, they can sell at good price at high USD, this will turnaround the company into a very profitable one for at least 1 to 1.5 years and will become big 5 of the glove companies. The share price today is only RM1.82 which has a huge potential to go up based on the production capacity of 4.14b and potential 10b compared with the other 6 glove campanies. Malaysia captures 65% of the world market and everyone of the world is eyeing our 7 listed companies to supply them with gloves for prevention of covid 19.

Can anyone give the feedback on how many existing production lines carepls have and what is the annual production.

Very great article written by Mr Koon and Mr OTB as the bull just started in March 2020 and the product of comfort is in great great great demand with 100% certainty for at least 1 to 1.5 years.

Coronavirus could last years, says Japanese economist urging more tests, support - Good Articles to Share | I3investor


Coronavirus could last years, says Japanese economist urging more tests, support
Author: Tan KW Publish date: Sat, 16 May 2020, 12:23 AM

TOKYO - Japan should boost coronavirus testing and offer more generous cash payouts to households as the epidemic could last for several years, an economist appointed to a government panel on the virus response said on Friday.

The government can fund huge spending on the coronavirus by issuing more bonds, which the central bank can buy to avoid causing a rise in long-term interest rates, said Keiichiro Kobayashi, who was appointed on Tuesday to join a committee advising the government on measures to combat the pandemic.

"It could take up to four years," he said, referring to the time needed to develop and distribute an effective vaccine or medicine to combat the virus.

Consumption will fall globally during that time, he said.

That means stronger measures are needed to keep Japan's economy from suffering prolonged, deep stagnation including paying 100,000 yen ($934) a month for every citizen that suffered a sharp drop in income from the outbreak, Kobayashi told Reuters.

The programme would cost the government up to 24 trillion yen, said Kobayashi, who is an economist at the private Tokyo Foundation for Policy Research.

The most important thing is to alleviate public anxiety about the coronavirus and its fallout, he said.

"It's necessary to take steps to make people feel safe by strengthening testing and isolation capabilities," Kobayashi said.

Kobayashi said he planned to share his proposals with Prime Minister Shinzo Abe and his cabinet.

The government appointed several private-sector economists to the panel, which had consisted mostly of medical experts, as efforts to contain the virus put deeper strains on an economy already on the cusp of deep recession.

Japan has reported nearly 16,000 coronavirus infections and over 650 deaths.




- Reuters

https://markets.businessinsider.com/news/stocks/oil-price-wti-could-go-negative-again-regulator-warns-traders-2020-5-1029202506

Private placement is for long term investors and not for retail investors and the company needs fund now for fast expansion to capitalise the best opportunity now for fast growth as the glove is in great great gteat demand. Dato Ong is a very far sighted young professional leader, 41 years old in chemical engineering who make the best decision to take over this company timely in February 2020 to move very fast profit growth for the company. All investors will benefit from their investments in this company as the share price will continue to go higher and higher.

Malaysia is lucky during this world crisis as glove sector captures 65% of the world market to save the nation economy as all other sectors are bad now. PM and businessman should focus and mobilise more resources to this sector to create more employment. As the demand for glove is in great great great demand for a long time, the share price of comfort will continue to go up higher and higher for a long time.